Targeting biodefense markets

Abstract

The World Vaccine Congress 2009 held in Washington D.C. (April 20-23, 2009) sponsored several sessions focused on the vaccine market targeting biodefense. On day one of the congress, a panel discussion outlined the federal progress in medical countermeasure preparedness that included emerging infections, influenza and biodefense focuses. The second session focused on the biodefense vaccine market with both government and industry members discussing the opportunities and challenges associated with the budding market. © 2009 Landes Bioscience.